NO932287L - 2'-deosky-2',2'-difluor(2,6,8-substituerte)purin-nukleosider med antiviralog anticanceraktivitet, og mellomprodukter - Google Patents

2'-deosky-2',2'-difluor(2,6,8-substituerte)purin-nukleosider med antiviralog anticanceraktivitet, og mellomprodukter

Info

Publication number
NO932287L
NO932287L NO932287A NO932287A NO932287L NO 932287 L NO932287 L NO 932287L NO 932287 A NO932287 A NO 932287A NO 932287 A NO932287 A NO 932287A NO 932287 L NO932287 L NO 932287L
Authority
NO
Norway
Prior art keywords
difluoro
intermediates
substituted
deosky
purine nucleosides
Prior art date
Application number
NO932287A
Other languages
English (en)
Norwegian (no)
Other versions
NO932287D0 (no
Inventor
Gerald Burr Grindey
Cora Sue Grossman
Larry Wayne Hertel
Julian Stanley Kroln
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO932287D0 publication Critical patent/NO932287D0/no
Publication of NO932287L publication Critical patent/NO932287L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO932287A 1992-06-22 1993-06-21 2'-deosky-2',2'-difluor(2,6,8-substituerte)purin-nukleosider med antiviralog anticanceraktivitet, og mellomprodukter NO932287L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90230492A 1992-06-22 1992-06-22

Publications (2)

Publication Number Publication Date
NO932287D0 NO932287D0 (no) 1993-06-21
NO932287L true NO932287L (no) 1993-12-23

Family

ID=25415652

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932287A NO932287L (no) 1992-06-22 1993-06-21 2'-deosky-2',2'-difluor(2,6,8-substituerte)purin-nukleosider med antiviralog anticanceraktivitet, og mellomprodukter

Country Status (14)

Country Link
EP (1) EP0576227A3 (fr)
JP (1) JPH0656877A (fr)
KR (1) KR940005656A (fr)
CN (1) CN1084178A (fr)
AU (1) AU4134793A (fr)
BR (1) BR9302433A (fr)
CA (1) CA2098876A1 (fr)
CZ (1) CZ123293A3 (fr)
FI (1) FI932868L (fr)
HU (1) HUT64553A (fr)
IL (1) IL106073A0 (fr)
MX (1) MX9303709A (fr)
NO (1) NO932287L (fr)
PL (1) PL299412A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
EP1019425A1 (fr) * 1996-01-23 2000-07-19 The Regents Of The University Of Michigan Nucleosides de benzimidazole modifies utilises comme agents antiviraux
BR9714349A (pt) * 1996-10-16 2000-11-14 Icn Pharmaceuticals L-nucleosìdeos purina, seus análogos e utilizacões dos mesmos
TW466112B (en) * 1998-04-14 2001-12-01 Lilly Co Eli Novel use of 2'-deoxy-2',2'-difluorocytidine for immunosuppressive therapy and pharmaceutical composition comprising the same
WO2003062256A1 (fr) * 2002-01-17 2003-07-31 Ribapharm Inc. Analogues d'adenosine 2'-beta-modifiee-6-substituee et leur utilisation en tant qu'agents antiviraux
CN1293884C (zh) * 2002-10-29 2007-01-10 南京长澳医药科技有限公司 6－甲氧基双脱氧鸟苷在制备抗乙肝药物中的应用
JP5002851B2 (ja) * 2005-01-20 2012-08-15 独立行政法人理化学研究所 イミダゾピリジン誘導体
CN100391966C (zh) * 2005-06-17 2008-06-04 华东师范大学 一种2’-脱氧-2’，2’-二氟-胞苷合成的方法
AT502635A1 (de) * 2005-11-09 2007-05-15 Saischek Und Partner Meg Neue 1,3-dithioverbindungen, verfahren zu deren herstellung und ihre verwendung
KR101442288B1 (ko) 2006-12-13 2014-09-19 지보당 네덜란드 서비시즈 비.브이. 카복실산과 퓨린, 피리미딘, 뉴클레오사이드 또는 뉴클레오타이드의 향미 조절 유도체
BRPI0719989B1 (pt) * 2006-12-13 2016-12-13 Givaudan Nederland Services Bv substâncias de modulação de sabor, composições aromatizantes e produtos compreendendo as mesmas, método de melhoramento do sabor de produtos, e processo de produção de preparação de sabor
CN106317147B (zh) * 2015-07-06 2018-11-27 扬州硒瑞恩生物医药科技有限公司 核苷类化合物及其制备方法
WO2018110643A1 (fr) * 2016-12-14 2018-06-21 ヤマサ醤油株式会社 Dérivé de nucléoside présentant une activité antivirale
JP7084591B2 (ja) * 2017-03-29 2022-06-15 ヤマサ醤油株式会社 ヌクレオシド誘導体又はその塩、及びそれを含む医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184365B1 (fr) * 1984-12-04 1993-08-04 Eli Lilly And Company Traitement de tumeurs chez les mammifères
CA1295998C (fr) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides et leur utilisation en tant qu'agents antineoplasiques
US4914028A (en) * 1988-02-10 1990-04-03 Eli Lilly And Company Method of preparing beta-2',2'-difluoronucleosides
EP0329348B1 (fr) * 1988-02-16 1995-07-12 Eli Lilly And Company Nucléosides-2',3'-didéoxy-2',2'-difluoro

Also Published As

Publication number Publication date
BR9302433A (pt) 1994-01-11
HUT64553A (en) 1994-01-28
CZ123293A3 (en) 1994-03-16
JPH0656877A (ja) 1994-03-01
NO932287D0 (no) 1993-06-21
CN1084178A (zh) 1994-03-23
AU4134793A (en) 1993-12-23
HU9301821D0 (en) 1993-09-28
EP0576227A2 (fr) 1993-12-29
CA2098876A1 (fr) 1993-12-23
IL106073A0 (en) 1993-10-20
EP0576227A3 (fr) 1994-02-09
MX9303709A (es) 1994-05-31
FI932868A0 (fi) 1993-06-21
PL299412A1 (en) 1993-12-27
FI932868A7 (fi) 1993-12-23
FI932868L (fi) 1993-12-23
KR940005656A (ko) 1994-03-22

Similar Documents

Publication Publication Date Title
NO932289L (no) 2'-deoksy-2',2'-difluor(4-substituerte pyrimidin)nukleosider med antiviralog anticanceraktivitet og mellomprodukter
NO932287L (no) 2'-deosky-2',2'-difluor(2,6,8-substituerte)purin-nukleosider med antiviralog anticanceraktivitet, og mellomprodukter
CY2186B1 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
IL98702A (en) 9-purinyl phosphonic acid derivatives their preparation and pharmaceutical compositions containing them
NO179710C (no) Nye fosfolipidderivater av nukleosider, og legemiddel inneholdende disse
IL89796A0 (en) Bis-(hydroxymethyl)cyclobutyl purine and pyrimidine derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
IL88765A (en) N-hydroxycycloalkyl or n-hydroxycycloalkenyl- substituted adenosine derivatives, methods for their preparation and pharmaceutical compositions, including antilipolytic compositions, containing the same
AU5831590A (en) 2-halo-9-(2-deoxy-2-fluoro-b-d-arabinofuranosyl) adenine nucleoside derivatives
IE940696L (en) Antiviral compounds
TW366339B (en) Derivatives of benzimidazolyl-cyclopentanediol, -cyclopentanol and -cyclopentenol, and pharmaceutical composition containing the same
IL98164A0 (en) Antiviral nucleoside derivatives,process for their preparation and pharmaceutical compositions containing them
FI91763C (fi) Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi
ZA892284B (en) Novel fluorophosphonate nucleotide derivatives
EP0330992A3 (fr) Dérivés de cyclobutane, procédés pour leur préparation et compositions pharmaceutiques les contenant
EP0335770A3 (fr) Dérivés de nucléotides de fluorophosphonates
NZ219440A (en) Nucleoside of c 5 sugar
IL63132A0 (en) Novel adenine nucleoside derivatives,their preparation andand pharmaceutical compositions containing them
IL93001A0 (en) Purine nucleosides and nucleotides,processes for the preparation thereof and pharmaceutical compositions containing the same
RU93005243A (ru) Производные гризеоловой кислоты
ZA916542B (en) New phospholipid derivatives of nucleosides,processes for their preparation and antiviral use
EP0516186A3 (en) Nucleosides and nucleoside analogues, pharmaceutical composition and processes for the preparation of the compounds
IL78206A (en) 2-amino-9-(4-hydroxy-3-(hydroxymethyl)butyl)-purine derivatives,their preparation and pharmaceutical compositions containing them
RU93046286A (ru) 2'-дезокси-2', 2'-дифтор (4-замещенный пиримидин)нуклеозиды, обладающие противовирусной и противораковой активностью, промежуточные соединения и способ лечения
IT7830286A0 (it) Sistema di pressurizzazione dell'aria per cabine per aerei.
JPS6429316A (en) Antitumor agent